Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenapanor for IBS-C in Pediatric Patients (6 to <12 Years Old)
NCT06553547Phase 2Completed
- Sponsor
- Ardelyx
- Start
- Jul 2024
- Primary completion
- Jul 2026
- Countries
- 1
01
Overview
A Phase 2 trial of tenapanor in irritable bowel syndrome (IBS), sponsored by Ardelyx. Started Jul 2024; status: completed.
02
Drugs
tenapanor
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT06553547.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06553547.